Transient growth hormone therapy to rats with low protein-inflicted intrauterine growth restriction does not prevent elevated blood pressure in later life

被引:7
作者
Plank, Christian [1 ,2 ]
Grillhoesl, Christian [1 ,2 ]
Oestreicher, Iris [2 ,3 ]
Meissner, Udo [2 ,4 ]
Struwe, Friedrich G. [2 ,5 ]
Rauh, Manfred [1 ,2 ]
Hartner, Andrea [1 ,2 ]
Rascher, Wolfgang [1 ,2 ]
Doetsch, Joerg [1 ,2 ]
机构
[1] Univ Klinikum Erlangen, Kinder & Jugendklin, D-91054 Erlangen, Germany
[2] Univ Erlangen Nurnberg, Dept Pediat & Adolescent Med, D-8520 Erlangen, Germany
[3] Charite, Klin Neonatol, D-13353 Berlin, Germany
[4] Leopoldina Krankenhaus Stadt Schweinfurt, D-97422 Schweinfurt, Germany
[5] Deutsch Zentrum Kinder & Jugendrheumatol, D-82467 Garmisch Partenkirchen, Germany
关键词
Growth hormone; programming; intrauterine growth restriction; small for gestational age;
D O I
10.1080/08977190802485442
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Intrauterine growth restriction (IUGR) is a risk factor for the development of hypertension in later life. Insulin-like growth factor I and growth hormone (GH) have the potential to improve metabolic syndrome after IUGR in adult animals. The objective of the present study was to examine whether transient GH treatment of pups after weaning can prevent the development of arterial hypertension in adult rats. IUGR was induced in Wistar rats by isocaloric protein restriction in pregnant dams and litter size was reduced to six male neonates after birth. Recombinant human GH was applied by daily subcutaneous injections at a dose of 3g/g body weight between days 24 and 60 of life. Control animals received vehicle treatment (VEH) only. Birth weight was significantly lower in low protein (LP) animals than in normal protein (NP) animals (5.10.3g vs. 5.90.7g, p0.05). Until weaning at day 23, LP animals reached similar body length, but had reduced body weight compared to NP animals. Intraarterially measured mean arterial blood pressure at day 120 was elevated in LP-VEH compared to NP-VEH animals (1136mmHg vs. 1016mmHg, p0.01). However, transient GH-treatment did not prevent arterial hypertension in LP animals (1125mmHg). Our data suggest that GH treatment between days 24 and 60 of life does not or at least not permanently reprogram blood pressure elevation after IUGR.
引用
收藏
页码:355 / 364
页数:10
相关论文
共 45 条
[1]   INTRAUTERINE PROGRAMMING OF ADULT DISEASE [J].
BARKER, DJP .
MOLECULAR MEDICINE TODAY, 1995, 1 (09) :418-423
[2]   Trajectories of growth among children who have coronary events as adults [J].
Barker, DJP ;
Osmond, C ;
Forsén, TJ ;
Kajantie, E ;
Eriksson, JG .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1802-1809
[3]   In utero programming of chronic disease [J].
Barker, DJP .
CLINICAL SCIENCE, 1998, 95 (02) :115-128
[4]  
Berger I, 2007, HISTOL HISTOPATHOL, V22, P1231, DOI 10.14670/HH-22.1231
[5]   The maternal diet during pregnancy programs altered expression of the glucocorticoid receptor and type 2 11β-hydroxysteroid dehydrogenase:: Potential molecular mechanisms underlying the programming of hypertension in utero [J].
Bertram, C ;
Trowern, AR ;
Copin, N ;
Jackson, AA ;
Whorwood, CB .
ENDOCRINOLOGY, 2001, 142 (07) :2841-2853
[6]   Animal models and programming of the metabolic syndrome [J].
Bertram, CE ;
Hanson, MA .
BRITISH MEDICAL BULLETIN, 2001, 60 :103-121
[7]   Is there an association between level of adult blood pressure and nephron number or renal filtration surface area? [J].
Black, MJ ;
Briscoe, TA ;
Constantinou, M ;
Kett, MM ;
Bertram, JF .
KIDNEY INTERNATIONAL, 2004, 65 (02) :582-588
[8]   Low dosages of exogenous growth hormone and its effect on growth in an animal model of suboptimal nutrition [J].
Carrillo, A ;
Rising, R ;
Cole, C ;
Tverskaya, R ;
Lifshitz, F .
NUTRITION, 2000, 16 (11-12) :1074-1078
[9]   Management of the child born small for gestational age through to adulthood: A consensus statement of the international societies of pediatric endocrinology and the Growth Hormone Research Society [J].
Clayton, P. E. ;
Cianfarani, S. ;
Czernichow, P. ;
Johannsson, G. ;
Rapaport, R. ;
Rogol, A. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (03) :804-810
[10]  
Delemarre E M, 2007, Eur J Endocrinol, V157 Suppl 1, pS47, DOI 10.1530/EJE-07-0163